克洛皮多格雷尔药物遗传学的实施:巴西的视角
J F Vieira1,2, I H Tassoni1, M L Chaves1,2
1Departamento de Patologia, Genética e Evolução, Instituto de Ciências Biológicas e Naturais, Universidade Federal do Triângulo Mineiro, Uberaba, Brasil.
Pharmacogenomics
|November 6, 2025
概括
CYP2C19基因变异会影响克洛皮多格雷尔的反应,影响心血管结果. 在巴西实施基因型导向策略需要解决针对个性化抗血小板治疗的当地挑战.
科学领域:
- 药物基因组学 药物基因组学
- 临床药理学 临床药理学
- 精准医学是一门精准的医学.
背景情况:
- CYP2C19基因对于抗血小板药物克洛皮多格雷尔的生物激活至关重要.
- CYP2C19的遗传变异导致患者的反应多样化,并可能导致更糟糕的心血管结果.
- 基因型导向策略显示出希望,但在像巴西人这样的多元人口中面临挑战.
研究的目的:
- 讨论CYP2C19基因定型在巴西的临床实施,用于克洛皮多格雷尔治疗.
- 在巴西背景下探索克服精准医学障碍的策略.
- 在HC-UFTM提出CYP2C19-clopidogrel药物遗传学的实施策略.
主要方法:
- 语境合成方法. 语境合成方法.
- 通过PubMed识别证据 (2025年7月更新).
- 对精准医学实施的结构性和科学障碍的分析.
主要成果:
- CYP2C19多态性显著影响克洛皮多格雷尔的疗效和安全性.
- 国际准则可能不直接适用于巴西的遗传多样性人口.
- 实施需要解决国家研究促进,基础设施,培训和公共政策的问题.
结论:
- 通过CYP2C19基因定型进行个性化皮多格雷尔治疗是有益的,但需要局部适应.
- 克服实施障碍对于巴西成功的精准医学至关重要.
- 需要在HC-UFTM和全国范围内针对CYP2C19-clopidogrel药物遗传学采取量身定制的方法.
相关概念视频
01:21Factors Affecting Drug Response: Overview
2.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.9K
01:10Pharmacokinetics: Overview
8.8K
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
8.8K
01:28Biopharmaceutics and Pharmacokinetics: Overview
3.2K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
3.2K
01:19Factors Affecting Drug Biotransformation: Biological
503
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
503
01:25Pharmacokinetics: Drug–Drug Interactions
332
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
332
01:12Analysis of Population Pharmacokinetic Data
659
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
659